| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/16/2001 | EP0649309B1 Use of particles of a biocompatible, bioabsorbable calcium salt as active principle in the preparation of a medicament for local treatment of bone demineralizing diseases |
| 08/16/2001 | EP0576483B1 Biocidal proteins |
| 08/16/2001 | DE10004857A1 MLP-Gen, Nukleinsäuren, Polypeptide und deren Verwendung MLP-gene nucleic acids, polypeptides and their use |
| 08/16/2001 | CA2800450A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2412143A1 Transgenic cells expressing glucosyltransferase nucleic acids |
| 08/16/2001 | CA2400497A1 Methods and compositions for generating angiostatin |
| 08/16/2001 | CA2400472A1 Il-17 like molecules and uses thereof |
| 08/16/2001 | CA2400299A1 Dna encoding human vanilloid receptor vr3 |
| 08/16/2001 | CA2400187A1 Protein c derivatives |
| 08/16/2001 | CA2399969A1 Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof |
| 08/16/2001 | CA2399945A1 Larynx carcinoma-associated protein larcap-1 |
| 08/16/2001 | CA2399873A1 Drug metabolizing enzymes |
| 08/16/2001 | CA2399860A1 Udp-galactose: .beta.-d-galactose-r 4-.alpha.-d-galactosyltransferase, .alpha.4gal-t1 |
| 08/16/2001 | CA2399689A1 Gene cluster encoding a nystatin polyketide synthase and its manipulation and utility |
| 08/16/2001 | CA2399623A1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 08/16/2001 | CA2399593A1 Antibodies to ccr5 |
| 08/16/2001 | CA2399391A1 Trade molecules and uses related thereto |
| 08/16/2001 | CA2399387A1 Heterologous polypeptide of the tnf family |
| 08/16/2001 | CA2399266A1 Improved galactosylation of recombinant glycoproteins |
| 08/16/2001 | CA2399148A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2399019A1 Proteins producing an altered immunogenic response and methods of making and using the same |
| 08/16/2001 | CA2398775A1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/16/2001 | CA2398750A1 Nucleozymes with endonuclease activity |
| 08/16/2001 | CA2398282A1 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression |
| 08/16/2001 | CA2368681A1 Anti-angiogenic intestinal peptides, zdint5 |
| 08/15/2001 | CN1308680A Genomic sequences upstream of the coding region of the G-CSF gene for protein production and delivery |
| 08/15/2001 | CN1308679A Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiquitous endoproteases |
| 08/15/2001 | CN1308678A Cultivar specificity gene from the rice pathogen i(magnaporthe grisea), and methods of use |
| 08/15/2001 | CN1308677A Human tumour-derived polyptde hormone phosphatonin |
| 08/15/2001 | CN1308675A Immunological reagent specifically interating with the extracellular domain of the human zeta chain |
| 08/15/2001 | CN1308673A Modifing the expression of the FSH beta gene by homologous recombination |
| 08/15/2001 | CN1308671A Myelin basic protein peptides and uses thereof |
| 08/15/2001 | CN1308637A Binding molecules derived from immunolobulins which do not trigger complement mediated lysis |
| 08/15/2001 | CN1308544A Treatment for diabetes |
| 08/15/2001 | CN1307902A Varicella preventing method using vaccine |
| 08/15/2001 | CN1307795A Plantlet cultivating utensil and its usage |
| 08/14/2001 | US6274789 Rice gene resistant to blast disease |
| 08/14/2001 | US6274711 Proteins and mimetics which function in regulating, controlling physiology, development, and differentiation of mammalian immune cells including hemopoietic type; cytotoxic t lymphocyte activated or associated antigen (ctla) |
| 08/14/2001 | US6274709 By immunocompetent cells of high molecular weight; at residue 70 is methionine or threonine, antigens for monoclonal antibodies; increases cytotoxicity of killer cells |
| 08/14/2001 | US6274562 Method of inhibiting the proliferation and causing the differentiation of cells with IGF-1 receptor antisense oligonucleotides |
| 08/14/2001 | US6274556 Administering polypeptide derivative to treat inflammatory bowel disease and to prevent leukocyte infiltration into tissues |
| 08/14/2001 | US6274554 Method for preventing and treating hearing loss using a neurturin protein product |
| 08/14/2001 | US6274378 Methods and compositions for obtaining mature dendritic cells |
| 08/14/2001 | US6274377 Inducing apoptosis in a mammalian cell by contacting with paraffin or agar |
| 08/14/2001 | US6274362 RGS-containing molecules and uses thereof |
| 08/14/2001 | US6274359 Amino acid sequence; for recombinant production of enzyme and production of 1-alpha, 25-dihydroxyvitamin d3; prevention, diagnosis and treatment of osteoporosis |
| 08/14/2001 | US6274354 Methods using cre-lox for production of recombinant adeno-associated viruses |
| 08/14/2001 | US6274353 Contacting sample with primer having 3'-hydroxyl terminus blocked with group that prevents chain extension, thermostable blocking group removing enzyme, thermostable polymerase, and nucleoside-5'-triphosphates; then heating |
| 08/14/2001 | US6274350 Dna sequences which encode enzymes of defined amino acid sequences; for efficient recombinant production |
| 08/14/2001 | US6274347 Contacting antibody producing cells with fusion protein of extracellular portion of human leukocyte adhesion molecule-1 and constant region of human immunoglobulin g1, then isolating antibodies |
| 08/14/2001 | US6274338 Human c-Maf compositions and methods of use thereof |
| 08/14/2001 | US6274332 Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene |
| 08/14/2001 | US6274322 Transfection kit; for use as nucleotide sequence tool during genetic engineering |
| 08/14/2001 | US6274318 Detecting modulators of enzyme activity; incubate enzymatic sample and inhibitor, detect reduce activity from enzyme |
| 08/14/2001 | US6274306 Isolating microorganism from sample; insert apparatus into sample, recover apparatus, release microorganisms |
| 08/14/2001 | US6274148 Hepatitis C virus asialoglycoproteins |
| 08/14/2001 | US6274145 To generate cytolytic t cells against abnormal cells; as markers for pathological or abnormal condition in diagnosis |
| 08/14/2001 | US6274139 For therapy of bacterial infections |
| 08/14/2001 | US6274136 Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease |
| 08/14/2001 | US6274134 Human cell adhesion protein AAMP-1 and uses thereof |
| 08/14/2001 | US6274117 Cytokines that bind the cell surface receptor Hek |
| 08/14/2001 | CA2200457C Biological analysis system self-calibration apparatus |
| 08/10/2001 | CA2331876A1 Water-soluble ligand-binding proteins and analogs of ligand-gated channels, crystals thereof and their use for screening ligands of ligand-gated ion channels |
| 08/09/2001 | WO2001057267A1 Methods and materials relating to cub domain polypeptides and polynucleotides |
| 08/09/2001 | WO2001057265A1 Methods and materials relating to metallocarboxypeptidase-like polypeptides and polynucleotides |
| 08/09/2001 | WO2001057261A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 08/09/2001 | WO2001057242A2 Methods of protein destabilization and uses thereof |
| 08/09/2001 | WO2001057233A2 Methods and materials relating to preadipocyte factor-1-like (pref-1-like) polypeptides and polynucleotides |
| 08/09/2001 | WO2001057226A1 Humanized anti-ccr2 antibodies and methods of use therefor |
| 08/09/2001 | WO2001057224A2 Allene oxide cyclase gene and use thereof for producing jasmonic acid |
| 08/09/2001 | WO2001057211A1 Soluble t cell receptor protein and method of constructing the same |
| 08/09/2001 | WO2001057208A2 Mlp gene, nucleic acids, polypeptides and the utilization thereof |
| 08/09/2001 | WO2001057207A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 08/09/2001 | WO2001057205A1 Selective killing of cells by activation of double-stranded rna dependent protein kinase-pkr |
| 08/09/2001 | WO2001057196A1 Plant adpglucose pyrophosphatase, method for the production thereof, its use in the production of assay devices and for obtaining transgenic plants |
| 08/09/2001 | WO2001057194A2 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 08/09/2001 | WO2001057193A2 Protein c derivatives |
| 08/09/2001 | WO2001057191A1 Generation of dopaminergic neurons from human nervous system stem cells |
| 08/09/2001 | WO2001057175A2 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 08/09/2001 | WO2001057088A1 RUMINANT MHC CLASS I-LIKE Fc RECEPTORS |
| 08/09/2001 | WO2001057085A2 G-protein coupled receptors |
| 08/09/2001 | WO2001057074A1 Ligands for fpr class receptors that induce a host immune response to a pathogen or inhibit hiv infection |
| 08/09/2001 | WO2001057067A1 Ligand for vascular endothelial growth factor receptor |
| 08/09/2001 | WO2001057060A1 Bcl-2-like polynucleotides, polypeptides, and antibodies |
| 08/09/2001 | WO2001057057A1 Mammalian sphingosine-1-phosphate phosphatase |
| 08/09/2001 | WO2001056603A1 Cd40-binding apc-activating molecules |
| 08/09/2001 | WO2001056379A1 A method of quieting a corneal inflammatory response |
| 08/09/2001 | WO2001056375A1 Tob gene-defective knockout nonhuman mammal |
| 08/09/2001 | WO2001021796A3 Gl50 molecules and uses therefor |
| 08/09/2001 | WO2001021767A3 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
| 08/09/2001 | WO2001019966A3 Isolation of muscle-derived stem cells and uses therefor |
| 08/09/2001 | WO2001019963A3 System and method for microwave cell lysing of small samples |
| 08/09/2001 | WO2001016312A3 Nucleic acid based modulators of gene expression |
| 08/09/2001 | WO2001007568A3 Muscle cells and their use in cardiac repair |
| 08/09/2001 | WO2001006949B1 In vitro repair of bone and/or cartilage defects |
| 08/09/2001 | WO2001005945A3 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 08/09/2001 | WO2001005940A3 Methods for producing and preparing cells for cell therapy |
| 08/09/2001 | WO2001004318A3 Myxoma virus genes for immune modulation |
| 08/09/2001 | WO2000073324A9 Modulation of gene expression in gastrointestinal inflammation |
| 08/09/2001 | WO2000070046A9 Secreted polypeptides and corresponding polynucleotides |